Annual Report under Regulation 34 of the SEBI (LODR) Regulations, 2015
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 3.7 pts more than Nifty Microcap 250 and 3.9 pts more than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Achyut Healthcare Limited has submitted its 30th Annual Report for the financial year 2024-25 to BSE, where it is listed on the SME platform (Security Code: 543499). The company's 30th Annual General Meeting is scheduled for Tuesday, September 30, 2025 at 3:00 PM at its registered office in Ahmedabad. Key agenda items include adoption of audited financial statements, re-appointment of Mr. Akshit M. Raycha as Non-Executive Director, appointment of M/s. Kamlesh M. Shah & Co. as Secretarial Auditors for a 5-year term (FY 2025-26 to 2029-30), and regularisation of Mr. Parag Dave and Mr. Rajesh Sutaria as Independent Directors. The company operates from Ahmedabad with statutory auditors M/s. Doshi Doshi & Co.
This is a routine regulatory compliance filing with no immediate material impact on shareholders. Investors should review the detailed financial statements, Board Report, and Management Discussion & Analysis sections of the Annual Report for insights into the company's actual financial performance and outlook.